Psychedelics are a hot topic, and a drug called ibogaine is receiving attention after a recent shoutout from U.S. President Donald Trump. University of Calgary psychedelics researcher Leah Mayo explains what ibogaine is, and why limited high-quality research has her hesitant to recommend it. For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.
این قسمت هنوز متن ندارد
میتوانید در پلیر گوشش کنید. در قسمتهایی که متن دارند، با زدن روی هر کلمه معنیاش را میبینید.
